Q
26.58
2.23 (9.16%)
| Penutupan Terdahulu | 24.35 |
| Buka | 24.53 |
| Jumlah Dagangan | 1,911,492 |
| Purata Dagangan (3B) | 1,428,964 |
| Modal Pasaran | 1,805,620,224 |
| Harga / Pendapatan (P/E Ke hadapan) | 10.52 |
| Harga / Jualan (P/S) | 0.690 |
| Harga / Buku (P/B) | 0.930 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Nov 2025 |
| Margin Keuntungan | -12.97% |
| Margin Operasi (TTM) | 7.03% |
| EPS Cair (TTM) | -5.23 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -2.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 90.01% |
| Nisbah Semasa (MRQ) | 1.20 |
| Aliran Tunai Operasi (OCF TTM) | 149.30 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 297.44 M |
| Pulangan Atas Aset (ROA TTM) | 1.12% |
| Pulangan Atas Ekuiti (ROE TTM) | -11.38% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | QuidelOrtho Corporation | Menurun | Menurun |
AISkor Stockmoo
0.2
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | 3.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.20 |
|
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.92% |
| % Dimiliki oleh Institusi | 112.82% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 33.00 (Citigroup, 24.15%) | Pegang |
| Median | 31.00 (16.63%) | |
| Rendah | 22.00 (JP Morgan, -17.23%) | Jual |
| Purata | 28.67 (7.86%) | |
| Jumlah | 2 Pegang, 1 Jual | |
| Harga Purata @ Panggilan | 23.11 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| JP Morgan | 07 Nov 2025 | 22.00 (-17.23%) | Jual | 20.35 |
| UBS | 06 Nov 2025 | 31.00 (16.63%) | Pegang | 21.26 |
| Citigroup | 07 Oct 2025 | 33.00 (24.15%) | Pegang | 27.71 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BUSKY JOSEPH M. | 26.58 | - | 4,770 | 126,787 |
| WIDDER KENNETH J | - | 28.14 | -4,026 | -113,292 |
| WILKINS JOSEPH D JR. | 27.50 | - | 370 | 10,175 |
| Jumlah Keseluruhan Kuantiti Bersih | 1,114 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 23,670 | |||
| Purata Pembelian Keseluruhan ($) | 27.04 | |||
| Purata Jualan Keseluruhan ($) | 28.14 | |||
| Julat Insider ($) | ||||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| WILKINS JOSEPH D JR. | Pengarah | 26 Nov 2025 | Beli (+) | 370 | 27.50 | 10,175 |
| WIDDER KENNETH J | Pengarah | 25 Nov 2025 | Jual (-) | 4,026 | 28.14 | 113,292 |
| WIDDER KENNETH J | Pengarah | 25 Nov 2025 | Pelaksanaan pilihan | 7,021 | - | - |
| BUSKY JOSEPH M. | Pegawai | 24 Nov 2025 | Beli (+) | 4,770 | 26.58 | 126,787 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 24 Nov 2025 | Pengumuman | QuidelOrtho To Participate In Upcoming Investor Conferences |
| 20 Nov 2025 | Pengumuman | The Power of Prevention: Detecting Diabetes Before It Strikes |
| 05 Nov 2025 | Pengumuman | QuidelOrtho Reports Third Quarter 2025 Financial Results |
| 03 Nov 2025 | Pengumuman | QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay |
| 23 Oct 2025 | Pengumuman | Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics |
| 22 Oct 2025 | Pengumuman | QuidelOrtho to Report Third Quarter 2025 Financial Results |
| 16 Oct 2025 | Pengumuman | QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025 |
| 25 Sep 2025 | Pengumuman | Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters |
| 22 Sep 2025 | Pengumuman | QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |